Zydus Lifesciences Limited (ZYDUSLIFE.NS)
INR 983.75
(0.43%)
INR 983.75
(0.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 32.27 Billion | 26.88 Billion | 21.04 Billion | 32.93 Billion | 25.05 Billion | 28.82 Billion |
| Net Income | 48.38 Billion | 25.82 Billion | 52.32 Billion | 22.84 Billion | 14.95 Billion | 23.82 Billion |
| Depreciation & Amortization | 7.64 Billion | 7.22 Billion | 7.36 Billion | 7.24 Billion | 6.96 Billion | 5.98 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -8.71 Billion | -2.35 Billion | -3.51 Billion | 1.86 Billion | 1.29 Billion | 6.37 Billion |
| Other non-cash items | -370 Million | -3.8 Billion | -35.12 Billion | 966 Million | 1.84 Billion | -7.36 Billion |
| Investing Cash Flow | -14.75 Billion | 11.71 Billion | 11.54 Billion | -7.22 Billion | -10.12 Billion | -57.38 Billion |
| Investments in PPE | -9.06 Billion | -10.3 Billion | -12.02 Billion | -8.54 Billion | -9.04 Billion | -10.57 Billion |
| Acquisitions | -7.2 Billion | 1.14 Billion | 2.07 Billion | 1.03 Billion | 1.56 Billion | -48.67 Billion |
| Investment purchases | -4.64 Billion | -2.6 Billion | -7.83 Billion | -400 Million | -1.85 Billion | -48.81 Billion |
| Sales/Maturities of investments | 4.62 Billion | 23.35 Billion | 751 Million | 101 Million | 285 Million | 1.35 Billion |
| Other Investing Activities | 9 Million | 125 Million | 28.58 Billion | 579 Million | -1.08 Billion | 49.32 Billion |
| Financing Cash Flow | -18.1 Billion | -44 Billion | -8.68 Billion | -25.48 Billion | -10.94 Billion | 18.84 Billion |
| Debt repayment | -3.92 Billion | -9.96 Billion | -14.2 Billion | -25.68 Billion | -7.85 Billion | -1.7 Billion |
| Dividends payments | -6.21 Billion | -2.67 Billion | -3.72 Billion | -15 Million | -8.56 Billion | -3.58 Billion |
| Common Stock Repurchased | -7.25 Billion | -8.63 Billion | - | -8.33 Billion | - | - |
| Common Stock Issuance | - | 18.59 Billion | - | 9.86 Billion | - | - |
| Other Financing Activities | -3.83 Billion | -41.33 Billion | 9.24 Billion | -1.32 Billion | 4.07 Billion | 24.13 Billion |
| Accounts receivables | -7.47 Billion | -8.48 Billion | -1.81 Billion | 4.31 Billion | 5.63 Billion | -6.42 Billion |
| Accounts payables | -448 Million | -1.7 Billion | -1.2 Billion | 1.7 Billion | 564 Million | -2.25 Billion |
| Inventory | -20 Million | 4.4 Billion | -5.25 Billion | -4.79 Billion | -1.01 Billion | -1 Billion |
| Other working capital | -771 Million | 3.42 Billion | 4.76 Billion | 643 Million | -3.89 Billion | 16.06 Billion |
| Cash at beginning of period | 4.87 Billion | 11.06 Billion | 10.87 Billion | 11.77 Billion | 7.78 Billion | 15.89 Billion |
| Cash at end of period | 4.13 Billion | 5.73 Billion | 34.6 Billion | 10.87 Billion | 11.77 Billion | 8.79 Billion |
| Capital Expenditure | -9.06 Billion | -10.3 Billion | -12.02 Billion | -8.54 Billion | -9.04 Billion | -10.57 Billion |
| Effect of forex changes on cash | -231 Million | 66 Million | 86 Million | -42 Million | 79 Million | 1.6 Billion |
| Net cash flow / Change in cash | -748 Million | -5.33 Billion | 23.72 Billion | -905 Million | 3.98 Billion | -7.1 Billion |
| Free Cash Flow | 23.21 Billion | 16.57 Billion | 9.01 Billion | 24.39 Billion | 16.01 Billion | 18.24 Billion |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 11.82 Billion | 48.38 Billion | 7.89 Billion | 8 Billion | 10.86 Billion | 25.82 Billion |
| Depreciation & Amortization | - | 7.64 Billion | 1.94 Billion | 1.84 Billion | 1.79 Billion | 7.22 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -8.71 Billion | - | - | - | -2.35 Billion |
| Other non-cash items | -11.82 Billion | -370 Million | -7.89 Billion | -8 Billion | -10.86 Billion | -3.8 Billion |
| Investing Cash Flow | - | -14.75 Billion | - | - | - | 11.71 Billion |
| Investments in PPE | - | -9.06 Billion | - | - | - | -10.3 Billion |
| Acquisitions | - | -7.2 Billion | - | - | - | 1.14 Billion |
| Investment purchases | - | -4.64 Billion | - | - | - | -2.6 Billion |
| Sales/Maturities of investments | - | 4.62 Billion | - | - | - | 23.35 Billion |
| Other Investing Activities | - | 9 Million | - | - | - | 125 Million |
| Financing Cash Flow | - | -18.1 Billion | - | - | - | -44 Billion |
| Debt repayment | - | -3.92 Billion | - | - | - | -9.96 Billion |
| Dividends payments | - | -6.21 Billion | - | - | - | -2.67 Billion |
| Common Stock Repurchased | - | -7.25 Billion | - | - | - | -8.63 Billion |
| Common Stock Issuance | - | - | - | - | - | 18.59 Billion |
| Other Financing Activities | - | -3.83 Billion | - | - | - | -41.33 Billion |
| Accounts receivables | - | -7.47 Billion | - | - | - | -8.48 Billion |
| Accounts payables | - | -448 Million | - | - | - | -1.7 Billion |
| Inventory | - | -20 Million | - | - | - | 4.4 Billion |
| Other working capital | - | -771 Million | - | - | - | 3.42 Billion |
| Cash at beginning of period | - | 4.87 Billion | 9.07 Billion | 5.38 Billion | 4.92 Billion | 11.06 Billion |
| Cash at end of period | - | 4.13 Billion | 12.96 Billion | 9.07 Billion | 8.52 Billion | 5.73 Billion |
| Capital Expenditure | - | -9.06 Billion | - | - | - | -10.3 Billion |
| Effect of forex changes on cash | - | -231 Million | - | - | - | 66 Million |
| Net cash flow / Change in cash | - | -748 Million | 3.89 Billion | 3.68 Billion | 3.59 Billion | -5.33 Billion |
| Free Cash Flow | - | 23.21 Billion | 3.89 Billion | 3.68 Billion | 3.59 Billion | 16.57 Billion |
INSPIRISYS
7237
STRRF
UPL
NFPDF
YNGN